ADT 2002 Annual Report Download - page 12

Download and view the complete annual report

Please find page 12 of the 2002 ADT annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 182

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182

Nellcor continues to drive advancements in pulse oximetry technology with the recent introduction
of the OXIMAX pulse oximetry system. For critically ill patients or for those undergoing surgery, the
MALLINCKRODT endotracheal, the SHILEY tracheostomy tubes and the DAR breathing systems are
industry leaders. Puritan Bennett is known around the world for its critical care ventilators, and
recently released HELIOS liquid oxygen system for patients in need of oxygen therapy at home.
Mallinckrodt Imaging is devoted to improving the diagnostic sciences of X-ray, MRI and Nuclear
medicine. By developing, manufacturing, and marketing contrast agents, radiopharmaceuticals and
delivery systems, Mallinckrodt Imaging helps enhance the utility and quality of images obtained via
these procedures. For nearly a century, Mallinckrodt Imaging has partnered with radiologists,
cardiologists, urologists and nuclear medicine physicians to improve the quality of diagnosis in multiple
disease states through well known branded products including CONRAY and OPTIRAY X-ray contrast
media agents, OPTIMARK MRI contrast media agents and thallium and MAG3 radiopharmaceutical
agents. The Mallinckrodt family of imaging products is sold into hospitals, radiopharmacies and
alternate site imaging centers throughout the world.
Tyco Healthcare’s Mallinckrodt Pharmaceutical Division comprises three businesses—Bulk
Pharmaceuticals (active pharmaceutical ingredients), Dosage Pharmaceuticals and Specialty Chemicals.
These businesses are connected by common chemical manufacturing technology and shared facilities.
The Bulk Pharmaceuticals business is the largest producer of narcotics in the United States and of
acetaminophen worldwide. Ninety-five percent of these products are used within the pharmaceutical
industry to manufacture dosage form drugs. The Dosage Pharmaceuticals segment has three distinct
segments: generic narcotic pharmaceuticals, branded central nervous systems products and contract
pharmaceutical manufacturing for third parties. These products are sold to major wholesalers and drug
store chains. The Specialty Chemicals business includes a wide array of specialty chemicals targeted at:
research and development and analytical laboratories; process materials used to manufacture
biopharmaceuticals; and specialty chemicals used to manufacture semiconductor chips, many of which
are sold under the J.T. Baker name.
The Retail Division of Tyco Healthcare consists of the Confab and Paragon Trade Brands
businesses. This division develops, manufactures and markets a wide variety of retail brand products for
the United States and Canadian retail markets. The Retail Division supplies a broad majority of retail
mass merchandisers, food stores and drug stores in these markets. The division is recognized within
continental North America as the industry leader for retail brand adult incontinent care, infant care
and feminine hygiene products. Through our ‘‘first-to-market’’ approach, Tyco Healthcare’s Retail
Division helps retailers such as Wal-Mart, Target, Kroger, Albertson’s, CVS, Walgreens, Loblaw and
Toys R Us manage their categories and build their own store brand presence with the high-quality
products consumers demand.
Tyco Healthcare International is responsible for the marketing, distribution and export of all Tyco
Healthcare Group products (excluding pharmaceuticals) outside of the United States. Tyco Healthcare
International markets directly to hospitals and medical professionals, as well as through independent
distributors, with a worldwide presence. Although the mix of product lines offered varies from country
to country, its operations are organized primarily into four geographic regions: Europe, Japan, the
Asia-Pacific region and Latin America.
Tyco Healthcare’s competitors include Johnson & Johnson, Becton Dickinson and C.R. Bard,
among others, and competition is based on breadth of product offerings, quality of product, service and
price.
10